http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CH-499540-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3e9445e5e3626f36e932c6451a928250
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-04
filingDate 1968-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b6d9550a714c15ef46163228550ae1a
publicationDate 1970-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CH-499540-A
titleOfInvention Process for the preparation of new derivatives of (1,4) -oxazino- (3,4-a) -isoquinoline and their salts
abstract (A) 1,4-Oxazino (3,4-alpha) isoquinolines - (I) R1 = H or lower alkoxy; R2 and R3 = lower alkoxy or, when R1 = H, R2 + R3 together form methylenedioxy - Am = an amino-, lower alkylamino-, lower dialkylamino-, morpholino-, 1-pyrrolidinyl-, piperidino-, piperazino-, 4-alkylpiperazino-, 4-hydroxyalkyl-piperazino- or 4-alkoxyalkyl-piperazino. - (B) Acid addition salts of (I) with organic and inorganic acids. - (I) have tranquillising activity and may be used in the treatment of fear, tension and excited conditions such as found in neuroses and psychoses.
priorityDate 1967-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449417715
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419518214
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432304881
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422140267
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1001
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66953
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421312712
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8421
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7751
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483142
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448917884
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69056332
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID309
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID158529816
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6577
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6578
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533569
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67770923
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19910037
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414003971
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73874
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID119092151
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4076
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419498183
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419508577
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71580
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457531102
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559084
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411290960
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559577
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID28123
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419540504
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91550
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419514216
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457574877
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451

Total number of triples: 49.